ATE91412T1 - Kalziumpantothenatzusammensetzung. - Google Patents

Kalziumpantothenatzusammensetzung.

Info

Publication number: ATE91412T1
Authority: AT; Austria
Prior art keywords: calcium pantothenate; ingredients; composite; stable; calcium
Prior art date: 1989-04-19

Application number

AT90304169T

Other languages

English (en)

Inventor

Junzou Yamashita

Yasuo Ono

Kunihiko Sumimura

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-04-19

Filing date

1990-04-19

Publication date

1993-07-15

1990-04-19 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1993-07-15 Application granted granted Critical

1993-07-15 Publication of ATE91412T1 publication Critical patent/ATE91412T1/de

Links

FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 title abstract 4
229960002079 calcium pantothenate Drugs 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 2
239000004615 ingredient Substances 0.000 abstract 3
239000002131 composite material Substances 0.000 abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 abstract 1
229960002401 calcium lactate Drugs 0.000 abstract 1
239000001527 calcium lactate Substances 0.000 abstract 1
235000011086 calcium lactate Nutrition 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000001035 drying Methods 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
229910052749 magnesium Inorganic materials 0.000 abstract 1
229960004658 magnesium lactate Drugs 0.000 abstract 1
239000000626 magnesium lactate Substances 0.000 abstract 1
235000015229 magnesium lactate Nutrition 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
238000003860 storage Methods 0.000 abstract 1
239000003826 tablet Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Fodder In General (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT90304169T 1989-04-19 1990-04-19 Kalziumpantothenatzusammensetzung. ATE91412T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP9963789		1989-04-19
JP17944089		1989-07-11

Publications (1)

Publication Number	Publication Date
ATE91412T1 true ATE91412T1 (de)	1993-07-15

Family

ID=26440747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90304169T ATE91412T1 (de)	1989-04-19	1990-04-19	Kalziumpantothenatzusammensetzung.

Country Status (8)

Country	Link
US (1)	US5089276A (de)
EP (1)	EP0394022B1 (de)
JP (1)	JP2891744B2 (de)
AT (1)	ATE91412T1 (de)
DE (1)	DE69002186T2 (de)
DK (1)	DK0394022T3 (de)
ES (1)	ES2058793T3 (de)
HU (1)	HU208626B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2252905B (en) *	1991-02-11	1995-05-10	Leung Lit Hung	An agent for correcting a deficiency of androgenic steroids
US6582940B1 (en)	1998-12-25	2003-06-24	Daiichi Fine Chemical Co., Ltd.	Method for producing calcium pantothenate
US8232081B2 (en) *	1999-09-21	2012-07-31	Basf Se	Methods and microorganisms for production of panto-compounds
US6509496B1 (en)	2000-10-19	2003-01-21	Nutrapure, Inc.	Process for making mineral, food or pharmaceutical grade salt products
US6887492B2 (en)	2000-12-14	2005-05-03	Leiner Health Services Corp.	Magnesium plus interactive agent delivery
JP4841130B2 (ja) *	2004-10-12	2011-12-21	武田薬品工業株式会社	安定化されたビタミン製剤
JP4615470B2 (ja) *	2006-03-29	2011-01-19	卓郎簑和田	大脳の認知力を用いた疾患治療・予防の方法および医薬
PT2164975E (pt)	2007-07-06	2012-03-08	Basf Se	Processo para a produção de uma solução aquosa de glicose
JP5534224B2 (ja) *	2007-07-31	2014-06-25	ディーエスエムアイピーアセッツビー．ブイ．	Ｎａ−ベータ−アラニネートおよびカルシウムパントテネートの合成方法
JP5524130B2 (ja) *	2011-05-19	2014-06-18	武田薬品工業株式会社	安定化されたビタミン製剤
WO2019013234A1 (ja)	2017-07-11	2019-01-17	武田コンシューマーヘルスケア株式会社	ビタミンｂ１類を配合する固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2864701A (en) *	1954-04-30	1958-12-16	Merck & Co Inc	Stabilized pantothenic acid compositions
US2992273A (en) *	1958-03-12	1961-07-11	Nopco Chem Co	Preparation of dense calcium pantothenate
US3092548A (en) *	1960-10-27	1963-06-04	Warren Teed Products Company	Method of treating peptic ulcers with pantothenic acid
US3247064A (en) *	1962-03-30	1966-04-19	Shionogi & Co	Multivitamin tablet stabilized with porous silica
RO68298A2 (ro) *	1975-08-05	1980-04-15	Intreprinderea De Medicamente,Ro	Compozitie pe baza de saruri organice de calciu si magneziu usor asimilabile si cu o solubilitate crescuta,si procedeu de preparare a acesteia

1990
- 1990-04-18 US US07/510,686 patent/US5089276A/en not_active Expired - Lifetime
- 1990-04-18 HU HU902470A patent/HU208626B/hu not_active IP Right Cessation
- 1990-04-18 JP JP2103901A patent/JP2891744B2/ja not_active Expired - Fee Related
- 1990-04-19 AT AT90304169T patent/ATE91412T1/de not_active IP Right Cessation
- 1990-04-19 EP EP90304169A patent/EP0394022B1/de not_active Expired - Lifetime
- 1990-04-19 DK DK90304169.7T patent/DK0394022T3/da active
- 1990-04-19 DE DE90304169T patent/DE69002186T2/de not_active Expired - Lifetime
- 1990-04-19 ES ES90304169T patent/ES2058793T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US5089276A (en)	1992-02-18
DK0394022T3 (da)	1993-08-23
DE69002186D1 (de)	1993-08-19
HU902470D0 (en)	1990-08-28
HU208626B (en)	1993-12-28
JP2891744B2 (ja)	1999-05-17
ES2058793T3 (es)	1994-11-01
HUT54040A (en)	1991-01-28
DE69002186T2 (de)	1994-01-27
EP0394022A1 (de)	1990-10-24
JPH03123729A (ja)	1991-05-27
EP0394022B1 (de)	1993-07-14

Legal Events

Date	Code	Title
1994-03-15	UEP	Publication of translation of european patent specification
2001-10-15	EEIH	Change in the person of patent owner
2007-01-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DK0394022T3 (da)	1993-08-23	Calciumpantothenatkomposition
JPS53138446A (en)	1978-12-02	Resin composition
JPS53127819A (en)	1978-11-08	Stabilization of l-asocorbic acid and its salt
JPS5686103A (en)	1981-07-13	Base for mosquito-repellent incense
JPS5350141A (en)	1978-05-08	Stabilization of prostaglandin and prostaglandin analogues
JPS57140723A (en)	1982-08-31	Preventing composition for hyperlipemia due to neutral fat
DK0651614T3 (da)	1999-02-01	Stabiliseret fødevaresammensætning
JPS5726587A (en)	1982-02-12	Stabilization of ascorbic acid oxidase
JPS55157643A (en)	1980-12-08	Polymer composition
JPS5411951A (en)	1979-01-29	Production of molded product of polyester
JPS52130905A (en)	1977-11-02	Medicinal composition
JPS5379860A (en)	1978-07-14	Preparation of 1-acyl-3-indolinone derivs.
JPS5328693A (en)	1978-03-17	Polyester polyestier rlow molded articles or other preliminary molded article
JPS5273996A (en)	1977-06-21	Preparation of polyesters
JPS5650958A (en)	1981-05-08	Resin composition
JPS5363457A (en)	1978-06-06	Jelly compositions
JPS5568286A (en)	1980-05-22	Culture medium of sawdust for fungus mycellia
JPS6430563A (en)	1989-02-01	Concentrated and dried juice of plum or watermelon and preparation thereof
JPS5283413A (en)	1977-07-12	Preparation of 3,3-dimethyl-4-pentenoic acid or its esters
KR920700658A (ko)	1992-08-10	칼륨 보충을 위한 약학 조성물
JPS5432487A (en)	1979-03-09	Preparation of 1-carbamoyluracils
JPS5278707A (en)	1977-07-02	Preparation of low aluminum ferro-silicon
MORITA et al.	1987	Effect of L-Ascorbic Acid and L-Ascorbyl Palmitate on the Peroxidation of Linoleic Acid: Relationship between Appearance of Reaction Mixture and Peroxidation of Linoleic Acid
JPS52100553A (en)	1977-08-23	Preparation of resin compositions
JPS53111345A (en)	1978-09-28	Resin composition